Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An update from Lantheus ( (LNTH) ) is now available.
Jeff Humphrey, MD, will no longer serve as Chief Medical Officer at Lantheus Holdings, Inc., with his last day being January 3, 2025. His departure is amicable and not due to any disagreements, and interim leadership of research and development will be handled by CEO Brian Markison and President Paul Blanchfield while a search for his replacement is conducted.
More about Lantheus
YTD Price Performance: 47.02%
Average Trading Volume: 995,222
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $6.34B
Learn more about LNTH stock on TipRanks’ Stock Analysis page.
